TY - JOUR A1 - Lindau, Simone A1 - Kohlhaas, Madeline A1 - Nosch, Michael A1 - Choorapoikayil, Suma A1 - Zacharowski, Kai A1 - Meybohm, Patrick T1 - Cell salvage using the continuous autotransfusion device CATSmart - an observational bicenter technical evaluation T2 - BMC anesthesiology N2 - Background: The use of cell salvage and autologous blood transfusion has become an important method of blood conservation. So far, there are no clinical data about the performance of the continuous autotransfusion device CATSmart. Methods: In total, 74 patients undergoing either cardiac or orthopedic surgery were included in this prospective, bicenter and observational technical evaluation to validate red cell separation process and washout quality of CATSmart. The target of red cell separation process was defined as a hematocrit value in the packed red cell unit of 55–75% and of washout quality of 80–100% removal ratio. Results: Hematocrit values measured by CATSmart and laboratory analysis were 78.5% [71.3%; 84.0%] and 73.7% [67.5%; 75.5%], respectively. Removal ratios for platelets 94.7% [88.2%; 96.7%], free hemoglobin 89.3% [85.2%; 94.9%], albumin 97.9% [96.6%; 98.5%], heparin 99.9% [99.9%; 100.0%], and potassium 92.5% [90.8%; 95.0%] were within the target range while removal of white blood cells was slightly worse 72.4% [57.9%; 87.3%]. Conclusion: The new autotransfusion device enables sufficient red cell separation and washout quality. KW - Cell salvage KW - Auto transfusion KW - Hematocrit value Y1 - 2018 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/50830 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-508306 SN - 1471-2253 N1 - Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. VL - 18 IS - 1, Art. 189 SP - 1 EP - 5 PB - BioMed Central CY - [s. l.] ER -